Skip to content

Clinical trials

Phase 1/2 Primary Myelofibrosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 1/2 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20141
20162
20191
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kartos Therapeutics, Inc.2
Bristol-Myers Squibb1
Constellation Pharmaceuticals1
French Innovative Leukemia Organisation1
Incyte Corporation1
Italfarmaco1
Novartis Pharmaceuticals1
Sumitomo Pharma America, Inc.1
Telios Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis10
Myeloproliferative Disorders4
Thrombocythemia, Essential3
Bone Marrow Diseases2
Hematologic Diseases2
Leukemia2
Myelodysplastic Syndromes2
Polycythemia Vera2
Blood Coagulation Disorders1
Blood Platelet Disorders1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.